Studies using the Broad Institute's Connectivity Map found that GHK significantly increased expression of DNA repair genes with 47 genes stimulated and 5 genes suppressed, providing a mechanism for cellular recovery from various forms of damage
Retatrutide considerations Retatrutide , the triple agonist targeting GLP-1, GIP, and glucagon receptors, is still in clinical trials but early data provides insight into its injection site reaction profile
The answer is short and simple: We dont know
Additionally, research to examine the newer and more potent weight-loss GLP-1 receptor agonists, semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly), would be particularly important.
Holistic recommendations for diet, exercise, and lifestyle modifications
Ghiyam, a longevity physician at Med Pod LA in Beverly Hills who joined the Live Well podcast to break down the peptide boom firsthand, buying from it is essentially Russian roulette